Current position:Home >Product >
6-[(3aS,4R,7aR)-6-[[tert-butyl(diphenyl)silyl]oxymethyl]-4-(hydroxymethyl)-5-[(1R,4E)-4-[(2-hydroxyphenyl)methylidene]-1-oxidanyl-hexyl]-1,3-bis(oxidanylidene)-3a,4,7,7a-tetrahydroisoindol-2-yl]hexanoic acid
6-[(3aS,4R,7aR)-6-[[tert-butyl(diphenyl)silyl]oxymethyl]-4-(hydroxymethyl)-5-[(1R,4E)-4-[(2-hydroxyphenyl)methylidene]-1-oxidanyl-hexyl]-1,3-bis(oxidanylidene)-3a,4,7,7a-tetrahydroisoindol-2-yl]hexanoic acid
|
|
Canonical SMILES:
CCC(=CC1=CC=CC=C1O)CCC(C2=C(CC3C(C2CO)C(=O)N(C3=O)CCCCCC(=O)O)CO[Si](C4=CC=CC=C4)(C5=CC=CC=C5)C(C)(C)C)O
Isomeric SMILES
CC/C(=C\C1=CC=CC=C1O)/CC[C@H](C2=C(C[C@@H]3[C@H]([C@H]2CO)C(=O)N(C3=O)CCCCCC(=O)O)CO[Si](C4=CC=CC=C4)(C5=CC=CC=C5)C(C)(C)C)O
InChI
InChI=1S/C45H57NO8Si/c1-5-31(27-32-17-14-15-22-38(32)48)24-25-39(49)41-33(28-36-42(37(41)29-47)44(53)46(43(36)52)26-16-8-13-23-40(50)51)30-54-55(45(2,3)4,34-18-9-6-10-19-34)35-20-11-7-12-21-35/h6-7,9-12,14-15,17-22,27,36-37,39,42,47-49H,5,8,13,16,23-26,28-30H2,1-4H3,(H,50,51)/b31-27+/t36-,37+,39-,42-/m1/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (3aS,4R,7aR)-6-ethyl-4-(hydroxymethyl)-5-[(1R,4E)-4-[(2-hydroxyphenyl)methylidene]-1-oxidanyl-heptyl]-2-[1-(phenylmethyl)piperidin-4-yl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione
- 6-[(3aS,4R,7aR)-4-(hydroxymethyl)-5-[(1R,4E)-4-[(2-hydroxyphenyl)methylidene]-1-oxidanyl-heptyl]-6-(methoxymethyl)-1,3-bis(oxidanylidene)-3a,4,7,7a-tetrahydroisoindol-2-yl]hexanoic acid
- 6-[(3aS,4R,7aR)-6-[[tert-butyl(diphenyl)silyl]oxymethyl]-4-(hydroxymethyl)-5-[(1R,4E)-4-[(2-hydroxyphenyl)methylidene]-1-oxidanyl-heptyl]-1,3-bis(oxidanylidene)-3a,4,7,7a-tetrahydroisoindol-2-yl]hexanoic acid
- (3aS,4R,7aR)-4-(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-6-methyl-2-propyl-3a,4,7,7a-tetrahydroisoindole-1,3-dione
- 6-[(3aS,4R,7aR)-6-ethyl-4-(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-1,3-bis(oxidanylidene)-3a,4,7,7a-tetrahydroisoindol-2-yl]hexanoic acid
- (3aS,4R,7aR)-4-(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-6-propyl-2-(thiophen-2-ylmethyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione
- (3aS,4R,7aR)-4-(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-2-phenyl-6-propyl-3a,4,7,7a-tetrahydroisoindole-1,3-dione
- [3-[(3aS,4R,7aR)-4-(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-1,3-bis(oxidanylidene)-6-propyl-3a,4,7,7a-tetrahydroisoindol-2-yl]phenyl]boronic acid
- methyl (3aS,4R,7aR)-4-(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-1,3-bis(oxidanylidene)-6-propan-2-yl-3a,4,7,7a-tetrahydroisoindole-2-carboxylate
- (3aS,4R,7aR)-2-cyclohexyl-4,6-bis(hydroxymethyl)-5-[(Z,1R)-5-(2-hydroxyphenyl)-1-oxidanyl-4-phenyl-pent-4-enyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione

